Skip to main content
. 2017 Dec 8;8(70):114603–114612. doi: 10.18632/oncotarget.23059

Figure 4. The prioritization results in the case study of LIHC.

Figure 4

(A) The GO and KEGG enrichment analysis results for top 10% lncRNAs of LIHC. (B) Survival analysis results of four candidate lncRNAs.